Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233 | 1,115 | 1,908 | 5,004 | 6,041 |
| Marketable Securities | N/A | N/A | N/A | 0 | 2,303 |
| Other current assets | 171 | 0 | 258 | 324 | 248 |
| TOTAL | $404 | $1,137 | $2,938 | $6,490 | $10,134 |
| Non-Current Assets | |||||
| PPE Net | N/A | 2 | 4 | 6 | 8 |
| Other Non-Current Assets | 33 | 33 | 33 | 33 | 33 |
| TOTAL | $33 | $35 | $37 | $39 | $41 |
| Total Assets | $437 | $1,172 | $2,975 | $6,529 | $10,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,164 | 788 | 312 | 401 | 312 |
| Accrued Expenses | 113 | 582 | 569 | 603 | 550 |
| TOTAL | $1,524 | $1,649 | $1,211 | $1,425 | $1,393 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,524 | $1,649 | $1,211 | $1,425 | $1,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,420 | 41,170 | 26,545 | 26,545 | 26,545 |
| Common Shares | 265 | 265 | 265 | 265 | 265 |
| Retained earnings | -293,069 | -292,275 | -289,841 | -286,305 | -282,421 |
| TOTAL | $-1,087 | $-477 | $1,764 | $5,104 | $8,782 |
| Total Liabilities And Equity | $437 | $1,172 | $2,975 | $6,529 | $10,175 |